Skip to Content
Merck
All Photos(1)

Key Documents

View All Documentation

Safety Information

84050

Sigma-Aldrich

Ruthenium(III) chloride hydrate

38.0-42.0% Ru basis

Synonym(s):

Ruthenium trichloride

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Linear Formula:
RuCl3 · xH2O
CAS Number:
14898-67-0
Molecular Weight:
207.43 (anhydrous basis)
EC Number:
233-167-5
MDL number:
MFCD00149844
UNSPSC Code:
12161600
PubChem Substance ID:
57652984
NACRES:
NA.22

form

powder

reaction suitability

core: ruthenium
reagent type: catalyst

concentration

38.0-42.0% Ru

SMILES string

O.Cl[Ru](Cl)Cl

InChI

1S/3ClH.H2O.Ru/h3*1H;1H2;/q;;;;+3/p-3

InChI key

BIXNGBXQRRXPLM-UHFFFAOYSA-K

Looking for similar products? Visit Product Comparison Guide

Application

  • Photocatalytic disinfection: A study highlighted the synthesis of silver-ruthenium bimetallic zinc oxide nanocomposites using Callistemon viminalis leaf extract. These nanocomposites demonstrated effective photocatalytic disinfection properties against Escherichia coli, presenting a promising application in antimicrobial coatings (Jha et al., 2024).
  • Photoelectrocatalysis for hydrogen production: RuO(2)/TiO(2) heterostructures were investigated for their potential in photoelectrocatalytic hydrogen evolution, combining experimental and theoretical approaches to highlight the efficiency of ruthenium-based materials in renewable energy technologies (Kaikhosravi et al., 2023).
  • Electrochemical applications: The study explored the electrochemical properties of mixed RuOx/MnOx electrodes, prepared by thermal decomposition from different precursors, showing significant implications for their use in energy storage and conversion systems (Petrucci et al., 2022).
  • Catalysis and electrocatalysis: Unprotected and interconnected Ru(0) nano-chain networks were examined for their advantages in catalysis and electrocatalysis, illustrating the benefits of unprotected surfaces for improved reaction kinetics and efficiency (Anantharaj et al., 2016).

Other Notes

Catalyst for oxidation reactions with an oxidant; review

Signal Word

Danger

Hazard Statements

H302,H314,H411

Hazard Classifications

Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Corr. 1B

Storage Class Code

8A - Combustible corrosive hazardous materials

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Regulatory Listings

Regulatory Listings are mainly provided for chemical products. Only limited information can be provided here for non-chemical products. No entry means none of the components are listed. It is the user’s obligation to ensure the safe and legal use of the product.

JAN Code

84050-5G-F:
84050-BULK-F:
84050-VAR-F:
84050-50VL-S-KC:
84050-1G-F:

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
BCCF0349
BCBV7106
BCBP6900V
BCBJ0667V
BCBD7960V

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

T. Hasegawa et al.
Chemistry Letters (Jpn), 1385-1385 (1985)
P.H.J. Carlsen et al
The Journal of Organic Chemistry, 46, 3936-3936 (1981)
E.S. Gore
Platinum Metals Rev., 27, 111-111 (1983)
Yao Zhang et al.
European journal of medicinal chemistry, 86, 449-455 (2014-09-10)
Ruthenium-based anticancer complexes have become increasingly popular for study over the last two decades. Although ruthenium complexes are currently being investigated in clinical trials, there are still some difficulties with their delivery and associated side effects. Human serum albumin (HSA)-based
Huaiyi Huang et al.
Dalton transactions (Cambridge, England : 2003), 44(35), 15602-15610 (2015-08-08)
Ruthenium complexes have been considered as promising substitutes for cisplatin in cancer chemotherapy. However, novel ruthenium-based therapies are faced with some limitations, such as unimpressive cytotoxicity toward solid tumors. Herein, we designed and synthesized phenyl-substituted terpyridyl ruthenium(ii) complexes ([Ru(tpy)(bpy)Cl](+) (Ru1)
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service